Eisai Co.

Infobox Company
company_name = Eisai Co., Ltd.
company_
company_type = Public KK (tyo|4523)
foundation = 1936
location = flagicon|Japan Tokyo, Japan
key_people = Haruo Naito, President & CEO
industry = Pharmaceuticals
revenue = profit ¥ 734.3 billion JPY (FY 2007)
net_income = loss ¥ -17.0 billion JPY (FY 2007)
num_employees = 10,686 (2007)
homepage = [http://www.eisai.co.jp/index-e.html www.eisai.co.jp] nihongo|Eisai Co., Ltd.|エーザイ株式会社|Ēzai Kabushiki-gaisha|tyo|4523 is one of the leading global pharmaceutical companies, ranking among the top 25. Headquartered in Tokyo, Japan, it has some 10,000 employees, among them about 1,500 in research. Two of the key molecules Eisai developed are donepezil (Aricept) and rabeprazole (Aciphex).

References

* " [http://www.eisai.co.jp/pdf/eannual/epdf2007an.pdf Eisai Annual Report 2007] "
* Michael Rosen, “ [http://wistechnology.com/articles/2945/ Leading global Big Pharma companies of 2005] ”, "WTN News", May 9 2006.

External links

*en icon [http://www.eisai.co.jp/index-e.html Eisai Co., Ltd.]
* [http://www.eisai.com/ Eisai, Inc. (U.S. pharmaceutical subsidiary)]